Skip to main content
Fig. 2 | Genome Medicine

Fig. 2

From: CEOP/IVE/GDP alternating regimen compared with CEOP as the first-line therapy for newly diagnosed patients with peripheral T cell lymphoma: results from a phase 2, multicenter, randomized, controlled clinical trial

Fig. 2

Gene Mutations in peripheral T cell lymphoma. a Gene mutations identified by whole exome sequencing and targeted sequencing in 62 patients. The percentage of patients with mutations was listed on the right. The mutations are classified into the categories indicated on the left. b Number and type of non-silent somatic mutations presented above, number and percentage of non-silent somatic single-nucleotide variants presented below. c Circos diagram presenting correlation between genes

Back to article page

Genome Medicine

ISSN: 1756-994X

Contact us